亚宝药业：已累计回购1.14%股份

Core Viewpoint - Yabao Pharmaceutical (600351.SH) has repurchased a total of 8 million shares, representing 1.14% of the company's total share capital, with a total expenditure of RMB 52.15 million as of October 30, 2025 [1] Summary by Category - Share Repurchase Details - The company has conducted share repurchases through centralized bidding [1] - The highest transaction price for the repurchased shares was RMB 6.65 per share, while the lowest was RMB 6.30 per share [1] - The total amount paid for the repurchase, excluding transaction fees, was RMB 52.15 million [1]